In a piece she writes for Newsweek, Sharon Begley says NIH's Cancer Genome Atlas "may be fatally flawed." And the price tag for TCGA means that "the atlas threatens to suck up ever-dwindling resources." The article explores the concept of the project and quotes scientists who argue that the its potential gain doesn't come close to justifying its expense.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.